Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?
Crossref DOI link: https://doi.org/10.1007/s10557-017-6720-7
Published Online: 2017-03-01
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Borah, Bijan J.
Pereira, Naveen
Farkouh, Michael E.
License valid from 2017-02-01